Immunological Mechanisms of Vaccine-Induced Protection against SARS-CoV-2 in Humans
No Thumbnail Available
Access rights
openAccess
CC BY
CC BY
publishedVersion
URL
Journal Title
Journal ISSN
Volume Title
A2 Katsausartikkeli tieteellisessä aikakauslehdessä
This publication is imported from Aalto University research portal.
View publication in the Research portal (opens in new window)
View/Open full text file from the Research portal (opens in new window)
Other link related to publication (opens in new window)
View publication in the Research portal (opens in new window)
View/Open full text file from the Research portal (opens in new window)
Other link related to publication (opens in new window)
Date
2021-12
Department
Major/Subject
Mcode
Degree programme
Language
en
Pages
15
Series
Immuno, Volume 1, issue 4, pp. 442-456
Abstract
The SARS-CoV-2 infection spread rapidly throughout the world and appears to involve in both humoral and cell-mediated immunity. SARS-CoV-2 is attached to host cells via binding to the viral spike (S) proteins and its cellular receptors angiotensin-converting enzyme 2 (ACE2). Consequently, the S protein is primed with serine proteases TMPRSS2 and TMPRSS4, which facilitate the fusion of viral and cellular membranes result in the entry of viral RNA into the host cell. Vaccines are urgently required to combat the coronavirus disease 2019 (COVID-19) outbreak and aid in the recovery to pre-pandemic levels of normality. The long-term protective immunity is provided by the vaccine antigen (or pathogen)-specific immune effectors and the activation of immune memory cells that can be efficiently and rapidly reactivated upon pathogen exposure. Research efforts aimed towards the design and development of vaccines for SARS-CoV-2 are increasing. Numerous coronavirus disease 2019 (COVID-19) vaccines have passed late-stage clinical investigations with promising outcomes. This review focuses on the present state and future prospects of COVID-19 vaccines research and development, with a particular emphasis on immunological mechanisms of various COVID-19vaccines such as adenoviral vector-based vaccines, mRNA vaccines, and DNA vaccines that elicits immunological responses against SARS-CoV-2 infections in humans.Description
Publisher Copyright: © 2021 by the authors.
Keywords
adenoviral vector-based vaccine, DNA vaccine, mRNA vaccine, SARS-CoV-2
Other note
Citation
Goyal, K, Goel, H, Baranwal, P, Tewary, A, Dixit, A, Pandey, A K, Benjamin, M, Tanwar, P, Dey, A, Khan, F, Pandey, P, Gupta, P K, Kumar, D, Roychoudhury, S, Jha, N K, Upadhyay, T K & Kesari, K K 2021, ' Immunological Mechanisms of Vaccine-Induced Protection against SARS-CoV-2 in Humans ', Immuno, vol. 1, no. 4, pp. 442-456 . https://doi.org/10.3390/immuno1040032